A recent development in the federal Drug Enforcement Administration has led to a request for an investigation. The DEA has asked the US Justice Department's internal watchdog to look into claims made by a whistleblower. The claims involve DEA agents and their alleged role in allowing fentanyl pills to enter the market.

The incident in question reportedly occurred in New Mexico. Further details about the situation and the investigation are available from KPRC 2 Houston, including the timeline of events and the actions taken by the DEA in response to the whistleblower's claims.